Bayer submits marketing authorization applications for finerenone in the U.S. and the EU
The FINANCIAL -- Bayer announced the submission of regulatory applications to the U.S. Food and Drug Administration (FDA) and the ...
The FINANCIAL -- Bayer announced the submission of regulatory applications to the U.S. Food and Drug Administration (FDA) and the ...
The FINANCIAL -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National ...